From: RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes
Investigators | Platform | Reported on-targeting (%) | Reported off-targeting (%) |
---|---|---|---|
Shalem et al., 2014 [39] | Single Cas platform | ~100 | 0–15b |
Wang et al., 2014 [41] | Single Cas platform | 97 | 0–29.5c |
Koike-Yusa et al., 2014 [42] | Single Cas platform | 12.7 | ~0.7d |
Tsai et al., 2014 [46] | Dual Cas platform | 3–40 | 0 |
Ran et al., 2013 [48] | Dual Cas platform | 40a | 0 |
Guilinger et al., 2014 [47] | Dual Cas platform | 8–22 | 0 |